Skip to main content
SpringerLink
Log in

Extensive Pathological Analysis of Selected Melanoma Sentinel Lymph Nodes: High Metastasis Detection Rates at Reduced Workload

  • Melanomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Extensive pathological workup of sentinel lymph nodes (SLNs) in melanoma detects more patients with metastasis-positive SLNs than do routine protocols, but at the cost of high laboratory workloads. We aimed to design a protocol that reduced this workload without compromising metastasis detection.

Methods

We analyzed 920 SLNs from 321 consecutive patients with melanoma by complete step sectioning and immunohistochemistry. We designed different models to theoretically reduce the number of histological sections examined and compared the results from these simulations with results obtained with our extended protocol, with the restricted national Danish protocol, and with the protocol recommended by the European Organization for Research and Treatment of Cancer (EORTC).

Results

The extended protocol increased the metastasis detection rate by 22% (95% confidence interval, 11–34; 30.8% vs. 25.2%, P < .0001) compared with the national Danish protocol, and it had a similar rate to that reported by the EORTC (30.8% vs. 29.4%, P = .6229). The workload associated with complete step sectioning could be reduced by 40% by focusing step sectioning on the SLNs with the highest gamma counts, while examining SLNs with lower gamma counts with one to three central sections. The false-negative rate for detecting metastases with this reduced protocol was 6% compared with complete step sectioning.

Conclusions

Combining complete step sectioning of SLNs with immunohistochemistry ensures high metastasis detection rates. Workloads can be markedly reduced with only a slight increase in the false-negative rate by focusing analysis on the SLNs most likely to contain metastases, i.e., those with the highest gamma counts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Scolyer RA, Thompson JF, McCarthy SW. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004;101:2141–2.

    Article  PubMed  Google Scholar 

  2. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004;100:1683–91.

    Article  PubMed  Google Scholar 

  3. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003;200:314–9.

    Article  PubMed  Google Scholar 

  4. Gietema HA, Vuylsteke RJ, de Jonge IA, et al. Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2004;57:618–20.

    Article  PubMed  CAS  Google Scholar 

  5. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005;29:305–17.

    Article  PubMed  Google Scholar 

  6. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617–27.

    Article  PubMed  CAS  Google Scholar 

  7. van Akkooi AC, de Wilt JH, Verhoef C, et al. High positive sentinel node identification rate by EORTC Melanoma Group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 2006;42:372–80.

    Article  PubMed  Google Scholar 

  8. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110–21.

    Article  PubMed  CAS  Google Scholar 

  9. Ranieri JM, Wagner JD, Azuaje R, et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 2002;9:975–81.

    Article  PubMed  Google Scholar 

  10. van Akkooi A, de WJ, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 2006;17:1578–85.

  11. Govindarajan A, Ghazarian DM, McCready DR, et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 2007;14:906–12.

    Article  PubMed  Google Scholar 

  12. Satzger I, Volker B, Al Ghazal M, et al. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 2007;50:764–72.

    Article  PubMed  CAS  Google Scholar 

  13. Debarbieux S, Duru G, Dalle S, et al. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 2007;157:58–67.

    Article  PubMed  CAS  Google Scholar 

  14. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 2007;14:2861–6.

    PubMed  Google Scholar 

  15. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol 1988;12:612–8.

    Article  PubMed  CAS  Google Scholar 

  16. Cserni G. Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol 2000;113:351–4.

    Article  PubMed  CAS  Google Scholar 

  17. Diaz LK, Hunt K, Ames F, et al. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 2003;27:385–9.

    Article  PubMed  Google Scholar 

  18. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003;238:538–49.

    PubMed  Google Scholar 

  19. Viehl CT, Guller U, Hamel CT, et al. Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients. World J Surg 2006;30:453–6.

    Article  PubMed  Google Scholar 

  20. Morton DL, Bostick PJ. Will the true sentinel node please stand? Ann Surg Oncol 1999;6:12–4.

    Article  PubMed  CAS  Google Scholar 

  21. Nathanson SD. Will the true sentinel node please stand? Ann Surg Oncol 1999;6:514–6.

    Article  PubMed  CAS  Google Scholar 

  22. Porter GA, Ross MI, Berman RS, et al. How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma? Surgery 2000;128:306–11.

    Article  PubMed  CAS  Google Scholar 

  23. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 2001;8:192–7.

    Article  PubMed  CAS  Google Scholar 

  24. Coit DG. The “true” sentinel lymph node: in search of an operational definition of a biological phenomenon. Ann Surg Oncol 2001;8:187–9.

    PubMed  CAS  Google Scholar 

  25. Uren RF. Let every node count! J Nucl Med 2001;42:452–3.

    PubMed  CAS  Google Scholar 

  26. Carlson GW, Murray DR, Thourani V, et al. The definition of the sentinel lymph node in melanoma based on radioactive counts. Ann Surg Oncol 2002;9:929–33.

    Article  PubMed  Google Scholar 

  27. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004;86:212–23.

    Article  PubMed  Google Scholar 

  28. Jacobs IA, Chang CK, DasGupta TK, et al. High isotope counts and sentinel node positivity in patients with melanoma. Arch Surg 2003;138:63–6.

    Article  PubMed  Google Scholar 

  29. Stewart LE, Tyler DS, Vollmer RT. The importance of total number of sentinel lymph nodes in patients with stage N0 cutaneous melanoma. Am J Clin Pathol 2005;124:77–82.

    Article  PubMed  Google Scholar 

  30. Kroon HM, Lowe L, Wong S, et al. What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma. J Surg Oncol 2007;95:623–8.

    Article  PubMed  Google Scholar 

  31. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635–48.

    PubMed  CAS  Google Scholar 

  32. Rousseau DL Jr, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 2003;10:569–74.

    Article  PubMed  Google Scholar 

  33. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453–63.

    Article  PubMed  CAS  Google Scholar 

  34. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 2003;27:1197–202.

    Article  PubMed  Google Scholar 

  35. Phillips WT, Andrews T, Liu H, et al. Evaluation of [(99m)Tc] liposomes as lymphoscintigraphic agents: comparison with [(99m)Tc] sulfur colloid and [(99m)Tc] human serum albumin. Nucl Med Biol 2001;28:435–44.

    Article  PubMed  CAS  Google Scholar 

  36. Nathanson SD, Anaya P, Karvelis KC, et al. Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Oncol 1997;4:104–10.

    Article  PubMed  CAS  Google Scholar 

  37. Bedrosian I, Scheff AM, Mick R, et al. 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med 1999;40:1143–8.

    PubMed  CAS  Google Scholar 

  38. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998;39:1185–90.

    PubMed  CAS  Google Scholar 

  39. Carlson GW, Murray DR, Lyles RH, et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003;10:575–81.

    Article  PubMed  Google Scholar 

  40. Ariyan S, Ariyan C, Farber LR, et al. Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma. J Am Coll Surg 2004;198:924–32.

    Article  PubMed  Google Scholar 

  41. Wagner JD, Gordon MS, Chuang TY, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000;89:453–62.

    Article  PubMed  CAS  Google Scholar 

  42. Vargas HI, Vargas MP, Venegas R, et al. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer. Am Surg 2003;69:886–90.

    PubMed  Google Scholar 

  43. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275–83.

    Article  PubMed  CAS  Google Scholar 

  44. de Kanter AY, Menke-Pluijmers MB, Henzen-Logmans SC, et al. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement. Eur J Surg Oncol 2006;32:498–501.

    Article  PubMed  Google Scholar 

  45. Wong SL, Morton DL, Thompson JF, et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol 2006;13:809–16.

    Article  PubMed  Google Scholar 

  46. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–17.

    Article  PubMed  CAS  Google Scholar 

  47. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–83.

    PubMed  CAS  Google Scholar 

  48. Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 2008;5:18–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, Aarhus University Hospital, Noerrebrogade 44, Aarhus C, 8000, Denmark

    Rikke Riber-Hansen MD & Stephen Jacques Hamilton-Dutoit MD, FRCPath

  2. Department of Plastic Surgery, Aarhus University Hospital, Aarhus, Denmark

    Pia Sjoegren MD

  3. Department of Pathology, Vejle Hospital, Vejle, Denmark

    Torben Steiniche MD, DMSc

Authors
  1. Rikke Riber-Hansen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pia Sjoegren MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen Jacques Hamilton-Dutoit MD, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Torben Steiniche MD, DMSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rikke Riber-Hansen MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riber-Hansen, R., Sjoegren, P., Hamilton-Dutoit, S.J. et al. Extensive Pathological Analysis of Selected Melanoma Sentinel Lymph Nodes: High Metastasis Detection Rates at Reduced Workload. Ann Surg Oncol 15, 1492–1501 (2008). https://doi.org/10.1245/s10434-008-9847-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-9847-8

Keywords

Search

Navigation